Tai-Yun Yang

The efficacy of 40 mg versus dose de-escalation to less than 40 mg of afatinib (Giotrif) as the first-line therapy for patients with primary lung adenocarcinoma harboring favorable epidermal growth factor mutations

Chien‐Ying Liu, Chih‐Liang Wang, Shih‐Hong Li et al. · Oncotarget · 2017 · 31 citations · Full text

Medicine, Oncology, Pharmacology +15

High levels of soluble GPR56/ADGRG1 are associated with positive rheumatoid factor and elevated tumor necrosis factor in patients with rheumatoid arthritis

Wen-Yi Tseng, Yeong‐Jian Jan Wu, Tai-Yun Yang et al. · Journal of Microbiology Immunology and Infection · 2017 · 23 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Expression and immunoaffinity purification of recombinant soluble human GPR56 protein for the analysis of GPR56 receptor shedding by ELISA

Tai-Yun Yang, Nien‐Yi Chiang, Wen-Yi Tseng et al. · Protein Expression and Purification · 2014 · 11 citations

Life Sciences, Biochemistry, Molecular Biology +8